NON SMALL CELL LUNG CANCER (SQUAMOUS OR NON SQUAMOUS)
Clinical trials for NON SMALL CELL LUNG CANCER (SQUAMOUS OR NON SQUAMOUS) explained in plain language.
Never miss a new study
Get alerted when new NON SMALL CELL LUNG CANCER (SQUAMOUS OR NON SQUAMOUS) trials appear
Sign up with your email to follow new studies for NON SMALL CELL LUNG CANCER (SQUAMOUS OR NON SQUAMOUS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Blood test may spare some lung cancer patients from chemotherapy
Disease control Not yet recruitingThis study aims to see if a simple blood test can identify people with advanced non-small cell lung cancer who can be treated effectively with immunotherapy alone, avoiding chemotherapy. About 275 participants with high PD-L1 levels and a low inflammation blood score (PTI=0) will…
Matched conditions: NON SMALL CELL LUNG CANCER (SQUAMOUS OR NON SQUAMOUS)
Phase: PHASE2 • Sponsor: UNICANCER • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
New hope for stage 4 lung cancer? trial combines experimental drug with standard therapy
Disease control Not yet recruitingThis study tests whether adding an experimental drug (EIK1001) to standard treatment (pembrolizumab plus chemotherapy) helps people with stage 4 non-small cell lung cancer live longer or stop their cancer from growing. About 750 adults whose cancer has spread will receive either …
Matched conditions: NON SMALL CELL LUNG CANCER (SQUAMOUS OR NON SQUAMOUS)
Phase: PHASE2, PHASE3 • Sponsor: Eikon Therapeutics • Aim: Disease control
Last updated May 11, 2026 20:46 UTC